Alpha-interferon for relapsed non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Alpha-interferon for relapsed non-Hodgkin's lymphoma

Published:2006-09-25 Issue:10 Volume:38 Page:701-702
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Armitage A E,Armitage J D,Armitage J O

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705509.pdf

Reference6 articles.

1. Vaishampayan U, Karanes C, Du W, Varterasian M, al-Katib A . Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation. Cancer Invest 2002; 20: 303–310.

2. Vose JM, Bierman PJ, Anderson JR, Kessinger A, Pierson J, Nelson J et al. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood 1992; 80: 2142–2148.

3. Jonasch E, Haluska FG . Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist 2001; 6: 34–55.

4. Armitage JO, Coiffier B . Activity of interferon-alpha in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma. Ann Oncol 2000; 11: 1–3.

5. Reichenberg A, Gorman JM, Dieterich DT . Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. Aids 2005; 19 (Suppl 3): S174–S178.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection;Alimentary Pharmacology & Therapeutics;2018-12-27

2. STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic Leukemia;Cell Reports;2018-09

3. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia;Journal for ImmunoTherapy of Cancer;2016-12

4. Maintenance therapy in diffuse large B-cell lymphoma;Current Opinion in Oncology;2012-09

5. Relapse of Lymphoma after Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome;Biology of Blood and Marrow Transplantation;2011-10